Ford’s Chinese auto joint venture partner in China, Jiangling Motors Co. Group, is planning to raise its presence in Europe next year to 500 car dealers. The company obviously believes it can do well…
It is not enough that Toyota expects a banner 2007, now Honda has jumped on the band wagon. The Japanese car company expects unit sales to rise 5% worldwide to 3.55 million. It also…
Stocks: (BCS)(BP)(BT)(GSK)(PUK)(RTRSY)(UL)(VOD)(BAY)(DCX)(DB)(DT)(SI)(ALA)(AXA)(FTE)(V) Markets in Europe were off slightly at 6.02 AM New York time. The FTSE was off .6% to 6,213. Barclays was down .6% to 718. BP was down .6% to 572. BT…
Stocks: (GSK)(EBAY)(TOMO)(HMC)(T)(BLS)(WMT)(YHOO) According to Reuters, GlaxoSmithKline Plc has bought global rights to Danish biotech company Genmab’s most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion. Reuters…
Stocks: (CAJ)(FUJ)(HIT)(HMC)(NIPNY)(NTT)(SNE)(TM)(CHL)(CN)(HBC)(PCW) Asian markets were off sharply. The Nikkei was down 1.1% to 16,777. Bridgestone was down 1.1% to 2660. Canon was down .6% to 6680. Daiwa Securities was down 1.6% to 1317. Fuji…
2006 ipo market 9 deals this week to end the bloated December calendar. With all the aggressive pricings and opens, most of the December ipo crop has not been able to hold initial opens…
From AAO Weblog Last Thursday, the Public Company Accounting Oversight Board issued its report on its 2005 inspection of PricewaterhouseCoopers. It found that the firm’s quality control was lacking in some audits: revenue and…
From BioHealth Investor Biotechnology BIOSANTE PHARMA INC +24.60% REPROS THERAPEUTICS +11.83% SUNESIS PHARMACEUTIC +11.72% POINT THERAPEUTICS +8.91% IMMTECH PHARM INC +8.38% Diagnostic Substances SYNOVA HEALTHCARE GR +21.82% NYMOX PHARM CORP +3.59% TRINITY BIO ADR…
From BioHealth Investor by H.S. AyoubBioHealthInvestor.com Shares of Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are down in after hours trading on Monday after issuing a letter to physicians and other prescribers regarding…
By William Trent, CFA of Stock Market Beat Oracle (ORCL) is trading down after reporting numbers that met earnings estimates but were weak with regard to sales. On the conference call, Chief Financial Officer…
By William Trent, CFA of Stock Market Beat Silicon Laboratories (SLAB) put out a Press Release after the market close, noting that one of their latest mobile handset chips has been adopted by Samsung.…
By Chad Brand of Peridot Capitalist A few years back CNBC, in partnership with MSN and some investment companies, began promoting the "StockScouter" ranking system. The quantitative formula ranked stocks using a 1-10 scale…
By Yser Anwar, CSC of Equity Investment Ideas Yesterday the FCC Commissioner McDowell announced he would not vote on the AT&T and BellSouth deal. It was widely expected that McDowell would cast the tie-breaking…
Barron’s beat up on chip maker SIRF this week. The company makes chips for GPS devices, and at one point had 90% of the market. But, one of the company’s big customers, TomTom, is…
Ebay has decided to get out of China, at least in terms of operating its own local language site. Chinese who buy from Ebay sites outside the country will still deal with Ebay. Chinese…
Hovnanian (HOV) ended up having killer numbers, sort of….their numbers got killed. If this is the bottom for the homebuilders, well you better look at the guidance for 2007 and do some forward multiple…
Cramer said you need to look at Internet companies not for value but you want them for growth. Cramer was discussing the next eBay (EBAY) as a stock called G-Market (GMKT). That is the…
Cramer said you can look for growth, but make sure youget the right growth. Everyoneone wants a hot stock, but very few determine what they really do. He will do 1 per day this…
by Jon C. OggDecember 18, 2006 Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are issuing a DEAR HEALTHCARE PROVIDER letter to physicians and other prescribers, including rheumatologists, neurologists, oncologists, hematologists, dermatologists, nephrologists, oncology…
Oracle (ORCL) met $0.22 EPS expectations, although as noted they have beat in each of the last 3 quarters and some were hoping for more. Revenues were $4.16 Billion instead of the $4.15 Billion…